Effects of mithramycin on Paget's disease of bone.
作者信息
Ryan W G, Schwartz T B, Perlia C P
出版信息
Trans Assoc Am Physicians. 1969;82:353-62.
PMID:5375158
Abstract
摘要
相似文献
1
Effects of mithramycin on Paget's disease of bone.
Trans Assoc Am Physicians. 1969;82:353-62.
2
Effects of mithramycin on Paget's disease of bone.
Ann Intern Med. 1969 Mar;70(3):549-57. doi: 10.7326/0003-4819-70-3-549.
3
Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
N Engl J Med. 1970 Sep 10;283(11):549-55. doi: 10.1056/NEJM197009102831101.
4
Treatment of Paget's disease with a diphosphonate (sodium etidronate).
Semin Drug Treat. 1972 Summer;2(1):77-81.
5
Treatment of Paget's disease with mithramycin: further experiences.
Semin Drug Treat. 1972 Summer;2(1):57-64.
6
Diphosphonates in Paget's disease.
Lancet. 1974 May 11;1(7863):894-8. doi: 10.1016/s0140-6736(74)90347-x.
7
Mithramycin in Paget's disease.
S Afr Med J. 1974 Jun 9;48(31):1328-30.
8
Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.
Am J Med. 1974 Mar;56(3):315-22. doi: 10.1016/0002-9343(74)90613-5.
9
Newer agents in treating Paget's disease of bone.
Geriatrics. 1974 Dec;29(12):61-9.
10
[Letter: Results of treatment of Paget's disease of bone with swine thyrocalcitonin].
Nouv Presse Med. 1975 Dec 13;4(43):3070-1.
引用本文的文献
1
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
PLoS One. 2013 Dec 19;8(12):e82220. doi: 10.1371/journal.pone.0082220. eCollection 2013.
Zotero 插件